EXEL vs RUN · P/E 17, rev $2.17B vs P/E 6.0, rev $2.04B
Exelixis Inc (EXEL) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported EXEL revenue for 2025-01-03 was $2.17B. Net income was $521.3M. Revenue was up 18.5% from 2023-12-29 to 2025-01-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the EXEL and RUN stock pages for the full models.
Not investment advice.